Figure 5.
Kinetics of disease progression in GKO and WT mice. GKO mice (n = 11) and control WT mice (n = 10) were immunized with 150 μg IRBP emulsified in CFA and received 0.5 μg of PT IP. Clinical development of disease was followed by fundus examination at the specified time points after immunization. The EAU score is the average of all the mice in the group ± SE.